Trials / Unknown
UnknownNCT00999791
Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Diffuse Macular Edema is the main cause of visual disorders in diabetic patients. Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe dosage is identified that can be used in diffuse diabetic macular edema for treatment. in this study, we are going to compare the effect of intra vitreal injection of Diclofenac and Bevacizumab in primary treatment of diffuse diabetic macular edema.
Detailed description
Diffuse Macular Edema is the main cause of visual disorders in diabetic patients. Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe dosage is identified that can be used in diffuse diabetic macular edema for treatment. in this study, we are going to compare the effect of intra vitreal injection of Diclofenac and Bevacizumab in primary treatment of diffuse diabetic macular edema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab | |
| DRUG | Diclofenac |
Timeline
- Start date
- 2009-07-01
- First posted
- 2009-10-22
- Last updated
- 2010-05-04
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00999791. Inclusion in this directory is not an endorsement.